Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126801521 | 12680152 | 1 | I | 20160810 | 20160824 | 20160824 | EXP | GB-MHRA-MIDB-8F2944C9-C089-4381-8861-4BB617795A1A | GB-TEVA-685516ACC | TEVA | 90.00 | YR | F | Y | 0.00000 | 20160824 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126801521 | 12680152 | 1 | PS | NITROFURANTOIN. | NITROFURANTOIN | 1 | 3 DAY COURSE | U | 73696 | ||||||||||
| 126801521 | 12680152 | 2 | SS | SOLIFENACIN | SOLIFENACIN | 1 | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126801521 | 12680152 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126801521 | 12680152 | Mouth ulceration | |
| 126801521 | 12680152 | Oral mucosal blistering |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126801521 | 12680152 | 1 | 20160717 | 20160720 | 0 |